Net Cash Provided by (Used in) Operating Activities |
-382K |
USD |
-11.7% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
1.36M |
USD |
+849% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-977K |
USD |
-589% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-2.25K |
USD |
-346% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
230K |
USD |
+7.19% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
739K |
USD |
+83.5% |
Q4 2023 |
FY 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Gross |
739K |
USD |
+83.5% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
0 |
USD |
-100% |
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
0 |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |